Skip to main content

Table 1 General clinical data of all study participants

From: Ultrasonic assessment of liver stiffness and carotid artery elasticity in patients with chronic viral hepatitis

 

Control Group

n = 64

Patients with chronic viral hepatitis

F

P

Patients with CHB

n = 147

Patients with CHC

n = 70

Age, Years

45.8 ± 10.6

46.5 ± 12.2

47.6 ± 12.1

0.400

0.670

Men Percentage, Count (%)

43(67)

98(67)

47(67)

–

–

Systolic pressure, mmHg

115.7 ± 11.6

116.2 ± 13.1

119.7 ± 12.8

2.166

0.177

Diastolic, pressure mmHg

71.2 ± 8.7

73.2 ± 8.6

71.2 ± 8.6

1.872

0.156

Blood Glu, mmol/L

4.9 ± 0.5

5.3 ± 1.1

6.0 ± 1.7

15.933

< 0.001

Glycated haemoglobin, %

5.3 ± 0.5

5.5 ± 1.4

6.8 ± 1.6

30.804

< 0.001

BMI, Kg/m2

23.2 ± 2.6

23.5 ± 3.0

24.4 ± 3.4

2.936

0.055

Cholesterol, mmol/L

3.8 ± 1.1

3.8 ± 1.3

3.7 ± 1.1

0.373

0.689

Triglycerides, mmol/L

1.2 ± 0.7

1.2 ± 0.5

1.2 ± 0.6

0.185

0.831

LDL, mmol/L

1.9 ± 0.8

1.8 ± 0.8

1.7 ± 0.8

0.695

0.500

HDL, mmol/L

1.0 ± 0.3

1.2 ± 0.4

1.1 ± 0.5

3.115

0.046*

Platelets, 109 /L

187.6 ± 70.2

137.4 ± 77.8

138.3 ± 64.3

11.598

< 0.001

AST, U/L

23.8 ± 8.7

45.8 ± 34.2

37.7 ± 24.6

13.927

< 0.001

ALT, U/L

28.5 ± 13.8

46.1 ± 38.5

43.1 ± 40.4

5.765

0.004

Albumin, g/L

43.8 ± 7.4

40.9 ± 8.9

40.8 ± 8.2

3.104

0.046*

Globulin, g/L

24.2 ± 6.3

25.3 ± 7.2

24.9 ± 7.1

0.566

0.569

  1. Note: CHB chronic hepatitis B, CHC chronic hepatitis C, BMI Body mass index, LDL Low-density lipoprotein, HDL High-density lipoprotein, AST Aspartate aminotransferase, ALT Alanine aminotransferase. * P < 0.05 when compared to the control group